Clinical trial for Diabetic Retinopathy
Official title Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
ClinicalTrials.gov ID: NCT07236879
What this study is testing
- What it's testing
- The study compares AI‑based interpretation of eye photos with readings by eye doctors to see if the AI can reliably detect diabetic retinopathy and macular edema.
- Who it's for
- Adults with diabetes who visit a primary care clinic and can have eye photos taken.
- What's involved
- Participants will have eye photos taken by a trained nursing assistant with a portable camera. The photos will be read by the AI and by an ophthalmologist, and the results will be compared.
- Time commitment
- The study involves a single visit for photo taking and no additional follow‑up visits are required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (\> 18 years old) diagnosed with diabetes mellitus who agree to participate in the study.
You likely can't join if
- Any contraindication for pharmacological mydriasis (such as knowledge of having closed-angle glaucoma, pregnancy).
- Life expectancy less than 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Porto Alegre, Rio Grande do Sul, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Porto Alegre, Rio Grande do Sul, Brazil. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.